2026 ICD-10-CM Diagnosis Code C75.5Malignant neoplasm of aortic body and other paraganglia
ICD-10-CM Codes›C00–D49›C73-C75›C75
- Billable — Valid for Submission
- Chronic Condition
C75.5 is a billable ICD-10-CM diagnosis code for malignant neoplasm of aortic body and other paraganglia. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). Coders also document this condition as adenocarcinoma of paraganglia. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Endocrine system cancers - all other types.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Adenocarcinoma of paraganglia
- Neoplasm of aortic body
- Neoplasm of glomus jugulare
- Neoplasm of para-aortic body
- Paraspinal neuroblastoma
- Primary adenocarcinoma of paraganglia
- Primary malignant neoplasm of aortic body
- Primary malignant neoplasm of glomus jugulare
- Primary malignant neoplasm of para-aortic body
- Primary malignant neoplasm of paraganglion
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Paraganglioma - D44.7
- aortic body - D44.7
- malignant - C75.5
- extra-adrenal - D44.7
- malignant - C75.5
- unspecified site - C75.5
- glomus jugulare - D44.7
- malignant - C75.5
- malignant - C75.5
- unspecified site - C75.5
- nonchromaffin - D44.7
- malignant - C75.5
- unspecified site - C75.5
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Paraganglioma
- aortic body
- malignant
- Paraganglioma
- extra-adrenal
- malignant
- Paraganglioma
- extra-adrenal
- malignant
- unspecified site
- Paraganglioma
- glomus jugulare
- malignant
- Paraganglioma
- malignant
- Paraganglioma
- malignant
- unspecified site
- Paraganglioma
- nonchromaffin
- malignant
- Paraganglioma
- nonchromaffin
- malignant
- unspecified site
- Tumor
- aortic body
- malignant
- Tumor
- glomus
- jugulare
- malignant
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Table of NeoplasmsClinical
Anatomical sites in the Table of Neoplasms that reference this code family.
| Site | Malig. Primary | Malig. Secondary | Ca in situ | Benign | Uncertain | Unspec. |
|---|---|---|---|---|---|---|
| aortic body | C75.5 | C79.89 | – | D35.6 | D44.7 | D49.7 |
| glomus › jugularis | C75.5 | C79.89 | – | D35.6 | D44.7 | D49.7 |
| organ of Zuckerkandl | C75.5 | C79.89 | – | D35.6 | D44.7 | D49.7 |
| para-aortic body | C75.5 | C79.89 | – | D35.6 | D44.7 | D49.7 |
| paraganglion NEC | C75.5 | C79.89 | – | D35.6 | D44.7 | D49.7 |
| Zuckerkandl organ | C75.5 | C79.89 | – | D35.6 | D44.7 | D49.7 |
Patient EducationClinical
Cancer
Cancer is not just one disease but many diseases. Cancer begins in your cells, which are the building blocks of your body. Usually, your body forms new cells as needed, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should.
The full article covers:
- What is cancer?
- What are the types of cancer?
- How does cancer develop?
- What are the symptoms of cancer?
- How is cancer diagnosed?
- What are the treatments for cancer?
- Can cancer be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert C75.5 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About C75.5Overview
Is C75.5 a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report malignant neoplasm of aortic body and other paraganglia on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What is the ICD-9 equivalent of C75.5?
Under the General Equivalence Mappings, malignant neoplasm of aortic body and other paraganglia converts to ICD-9-CM 194.6 (mal neo paraganglia NEC). The mapping is a direct match.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
